# car t-cell therapy (blogs) — RSS Amplifier

Recent posts from the 1 feeds in the RSS Amplifier directory that cover car t-cell therapy.

Page: <https://rssamplifier.com/topics/car-t-cell-therapy/blogs>  
Feed: <https://rssamplifier.com/topics/car-t-cell-therapy/blogs.md>

---

## [EV-Pembro Beats Chemo in Muscle- Invasive Bladder Cancer](https://www.oncologynewscentral.com/bladder-cancer/perioperative-combination-beats-chemo-in-muscle-invasive-bladder-cancer)

_2026-08-21 · ONC_

Perioperative enfortumab vedotin plus pembrolizumab significantly improved survival compared with cisplatin-based chemotherapy in muscle-invasive bladder cancer.

## [Bottom Line “Bloodbath” Rages in Radiation Oncology](https://www.oncologynewscentral.com/oncology/bloodbath-for-the-bottom-line-rages-on-in-radiation-oncology)

_2026-08-21 · ONC_

Radiation oncology’s reimbursement cuts have turned into a “bloodbath,” some experts say. Here are some strategies to fight back.

## [Is It Time for a New Type of Cancer Physician?](https://www.oncologynewscentral.com/video/oncology/is-it-time-for-a-new-type-of-cancer-physician)

_2026-08-20 · ONC_

The dramatic increase in cancer survivorship is introducing questions about the ability of physicians to meet patient needs. Is it time to create a specialty for “survivorship physicians?”

## [Sonali M. Smith, MD](https://www.oncologynewscentral.com/contributor/sonali-m-smith)

_2026-08-20 · ONC_

Sonali M. Smith, MD, is the Elwood V. Jensen Professorship of Medicine and the chief, section of hematology/oncology at UChicago Medicine.

## [Em Shone, BSN, RN, OCN](https://www.oncologynewscentral.com/contributor/em-shone)

_2026-08-20 · ONC_

Em Shone, BSN, RN, OCN, is an oncology nurse located in Houston, Texas.

## [Shervin Tabrizi, MD](https://www.oncologynewscentral.com/contributor/shervin-tabrizi)

_2026-08-20 · ONC_

Shervin Tabrizi, MD, is an assistant professor of radiation oncology at the Perelman School of Medicine in Philadelphia, Pennsylvania.

## [Miriam Adina Knoll, MD](https://www.oncologynewscentral.com/contributor/miriam-knoll)

_2026-08-20 · ONC_

Miriam A. Knoll, MD, is a clinical assistant professor of medicine at the Donald and Barbara Zucker School of Medicine at Hofstra University/Northwell Health in Glen Oaks, New York.

## [Combo Shows Survival Benefits in Advanced Breast Cancer](https://www.oncologynewscentral.com/breast-cancer/giredestrant-plus-everolimus-extends-postprogression-benefit-in-advanced-breast-cancer)

_2026-08-20 · ONC_

Giredestrant plus everolimus improved progression-free survival after subsequent therapy and chemotherapy-free survival in ER-positive, HER2-negative advanced breast cancer.

## [News Scan](https://www.oncologynewscentral.com/news-scan)

_2026-08-19 · ONC_

A quick review of oncology headlines that matter most.

## [Challenging Clinical Case: A Pickleballer With CLL](https://www.oncologynewscentral.com/cll/challenging-clinical-case-a-71-year-old-retired-pickleballer-with-cll)

_2026-08-18 · ONC_

A 71-year-old retired engineer who regularly plays pickleball is preparing to undergo treatment for his CLL. How much do you know about treatment options and pivotal trials that inform care?

## [Brisk AI News Briefings (Sponsored)](https://crawlproof.com/a/dPtVy9tHb4r8)

_2026-08-18 · **Sponsored**_

Read AI summaries and listen to audio briefings for top stories.

## [Oncology News Central](https://www.oncologynewscentral.com/)

_2026-08-18 · ONC_

Oncology News Central

## [New Book Provides “Window to the Entirety of Oncology”](https://www.oncologynewscentral.com/cll/new-book-provides-window-to-the-entirety-of-oncology-through-the-history-of-cll)

_2026-08-18 · ONC_

The past and future of CLL care are presented as “a window to the entirety of oncology” in \*Ghosts in the Blood\*, set for release this September.

## [Community Oncology Alliance](https://www.oncologynewscentral.com/partners/community-oncology-alliance)

_2026-08-18 · ONC_

Serving as the voice of community oncology in Washington, DC, and across the country, the Community Oncology Alliance (COA) aims to improve patient care, offer professional growth for cancer care providers, and support practice operations. Individuals from every level of the cancer care delivery team, including oncologists, hematologists, pharmacists, oncology nurses and nurse practitioners,…

## [Meet Community Oncology’s “Energizer Bunny”](https://www.oncologynewscentral.com/oncology/meet-community-oncologys-energizer-bunny)

_2026-08-18 · ONC_

Harsha Vyas, MD, founded rural Georgia’s only physician-owned oncology practice 14 years ago. Here’s how he has kept cancer care flourishing where it didn’t before.

## [FDA Approves Multiple Myeloma Combo Regimen](https://www.oncologynewscentral.com/drugs/info/fda-approves-combination-regimen-for-relapsed-or-refractory-multiple-myeloma)

_2026-08-14 · ONC_

The FDA granted accelerated approval to iberdomide plus daratumumab and hyaluronidase-fihj and dexamethasone for adults with relapsed multiple myeloma.

## [Jeff Sharman, MD](https://www.oncologynewscentral.com/contributor/jeff-sharman)

_2026-08-13 · ONC_

Jeff Sharman, MD, is the director of research at the Willamette Valley Cancer Institute as well as the medical director of hematology research for The US Oncology Network.

## [New Therapies Reshape ALK- and ROS1-Mutated NSCLC Care](https://www.oncologynewscentral.com/nsclc/targeted-therapies-are-reshaping-alk-and-ros1-mutated-nsclc-care)

_2026-08-13 · ONC_

Sandip P. Patel, MD, shares which recent developments could affect clinical practice in ROS1- and ALK-positive non-small cell lung cancer.

## [Will FDA Follow EU in Approving Breast Cancer Drug?](https://www.oncologynewscentral.com/breast-cancer/will-the-fda-follow-the-eus-lead-on-camizestrant-in-breast-cancer)

_2026-08-13 · ONC_

The European Union’s recent approval of camizestrant using the SERENA-6 switch strategy could strengthen the drug’s case with regulators in the United States.

